Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-16

Clinical Trial Update: The Impact of Omega-3 Fatty Acid Supplements on Fibromyalgia Symptoms [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating omega-3 fatty acid supplements for fibromyalgia symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 Fatty Acid Supplements (Omega-3 fatty acids)

Snippet

Sponsor: Dr. Yoram Shir | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED